Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 298,211	$ 98,699
Marketable securities	34,383	34,934
Accounts receivable, net of allowances of $513 and $520	48,105	50,836
Inventory	43,864	45,407
Prepaid expenses and other current assets	21,502	13,314
Total current assets	446,065	243,190
Restricted cash	322	322
Lease right-of-use assets	14,266	15,020
Property, plant and equipment, net	40,897	42,114
Goodwill	12,432	12,448
Other assets, net	1,717	2,116
Total assets	515,699	315,210
Current liabilities:
Accounts payable	19,125	20,890
Accrued liabilities	16,929	19,052
Deferred revenues	4,093	1,489
Current portion of lease liabilities	2,902	2,776
Line of credit	20,000	20,000
Total current liabilities	63,049	64,207
Non-current income taxes payable	5,991	5,902
Long-term lease liabilities	12,681	13,431
Other long-term liabilities	4,741	4,921
Total liabilities	86,462	88,461
Stockholders' equity:
Common stock - $0.0001 par value; 190,000 shares authorized, 56,406 and 51,163 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively	17	16
Additional paid-in capital	780,482	578,360
Accumulated other comprehensive loss	(3,344)	(3,064)
Accumulated deficit	(347,918)	(348,563)
Total stockholders’ equity	429,237	226,749
Total liabilities and stockholders’ equity	$ 515,699	$ 315,210